Tenaya Therapeutics, Inc.

NASDAQ:TNYA

Biotechnology

Healthcare
$0.31 -0.58%

-$0.00 today

Market cap
$69.95M
Beta
2.82
P/E (TTM)
-1.3
EPS (TTM)
-$0.54
52W Low $0.53High $2.35

Volume 2.77M

Average 3.79M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$93.33M

FY 2025 · Annual

Net Income

-$90.60M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue4.03M8.71M8.69M8.47M8.44M
Gross Profit(4.03M)(8.71M)(8.69M)(8.47M)(8.44M)
Gross Margin—————
Research & Development54.39M94.54M98.04M86.74M68.61M
Selling, General & Admin14.39M22.37M24.47M20.74M24.72M
Operating Expenses68.78M116.91M122.51M107.48M84.9M
Depreciation & Amortization4.03M8.71M8.69M8.47M8.44M
EBITDA(68.7M)(114.95M)(115.4M)(102.66M)(82.16M)
EBITDA Margin—————
Operating Income(72.81M)(125.62M)(131.19M)(115.95M)(93.33M)
Operating Margin—————
Interest Income108K1.95M7.06M4.74M2.68M
Interest Expense00000
Other Income / Expenses85K1.96M7.11M4.82M2.73M
Income Before Tax(72.72M)(123.67M)(124.08M)(111.13M)(90.6M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(72.72M)(123.67M)(124.08M)(111.13M)(90.6M)
Net Margin—————
EPS (Basic)(1.69)(2.76)(1.68)(1.31)(0.59)
EPS (Diluted)(1.69)(2.76)(1.68)(1.31)(0.59)
Weighted Avg Shares41.29M44.82M73.79M84.82M152.97M
Weighted Avg Shares (Diluted)41.29M44.82M73.79M84.82M152.97M

TNYA Earnings Waterfall · TTM

NASDAQ:TNYA · Revenue to Net Income

Key Ratios

EPS$-0.47
Gross Margin-170.9%
Net Margin-2141.3%
P/E Ratio-1.8
P/S Ratio117.7

Analysis

$225.0K of revenue converted into -$83.0M of net income for the selected period. Gross margin is -170.9% and net margin is -2141.3%, showing how much revenue survives after costs and taxes. EPS is $-0.47, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
DEF 14ADEF 14A filingOct 23, 2026
DEFA14ADEFA14A filingOct 23, 2026
PRE 14APRE 14A filingOct 13, 2026

How much revenue does TNYA generate?

Tenaya Therapeutics, Inc. (TNYA) reported $0.00 of revenue in fiscal 2025.

Is TNYA profitable?

Tenaya Therapeutics, Inc. (TNYA) reported -$90.60M of net income.